15h
New treatment approach improves survival, reduces recurrence risk in muscle-invasive bladder cancer
Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results